Proactive Investors - Run By Investors For Investors

Biome Grow's latest brand is from the Great Lakes area of Ontario

Great Lakes Cannabis derives its name from the Great Lakes that edge the province of Ontario. Great Lakes Cannabis is a separate production facility that is interconnected with Biome’s other regional brands, creating a unified Canadian cannabis biome.
Frozen lake
Biome Grow has unveiled its Ontario-based subsidiary and brand, Great Lakes Cannabis Co

Biome Grow Inc (CSE:BIO) has unveiled a new brand, Great Lakes Cannabis.

The new subsidiary trading under the brand is located in Norwich, Ontario.

Great Lakes Cannabis will serve Biome’s national and international markets with cannabis grown in Canada.

READ: Biome Grow's new subsidiary will sell craft cannabis to residents and tourists of Prince Edward Island

Great Lakes Cannabis is a late stage applicant to the Access to Cannabis for Medical Purposes Regulations (ACMPR).

Great Lakes Cannabis expects to be in a position to receive a cultivation licence shortly after work on its Norwich production facility is finished.

“Our Great Lakes Cannabis brand and facility will primarily supply cannabis products to the other provinces that Biome operates in until domestic production capacity in those other provinces is sufficiently brought online,” said chief executive officer, Khurram Malik.

“Longer term and subject to applicable legal requirements we see Great Lakes Cannabis supporting the international markets that we’ve been cultivating for future growth,” Malik added.

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full BIO profile View Profile

Biome Grow Inc. Timeline

Newswire
January 03 2019

Related Articles

cannabis facility
January 24 2019
The company is breaking into the large and lucrative market in the golden state
The R&D programme is intended to address the increasing prevalence of obesity and diabetes using smart siRNA
October 31 2018
The health sciences company noted that the plan was formulated at a recently held two-day intensive workshop which together leading scientific teams from the QIMR Berghofer Medical Research Institute in Brisbane and Murdoch University in Perth
cannabis facility
January 24 2019
The company will capitalize on the need for indoor-grown, pharmaceutical-grade cannabis

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use